Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Lyme disease-a tick-borne spirochetosis?

Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP.

Science. 1982 Jun 18;216(4552):1317-9.

PMID:
7043737
2.

The spirochetal etiology of Lyme disease.

Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE.

N Engl J Med. 1983 Mar 31;308(13):733-40.

PMID:
6828118
3.

Treatment of the early manifestations of Lyme disease.

Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, Malawista SE.

Ann Intern Med. 1983 Jul;99(1):22-6.

PMID:
6407378
4.

Isolation and cultivation of Lyme disease spirochetes.

Barbour AG.

Yale J Biol Med. 1984 Jul-Aug;57(4):521-5.

5.

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin.

Steere AC, Pachner AR, Malawista SE.

Ann Intern Med. 1983 Dec;99(6):767-72.

PMID:
6316826
7.

The penetration of ceftriaxone into synovial fluid of the inflamed joint.

Morgan JR, Paull A, O'Sullivan M, Williams BD.

J Antimicrob Chemother. 1985 Sep;16(3):367-71.

PMID:
4055544
8.

Successful parenteral penicillin therapy of established Lyme arthritis.

Steere AC, Green J, Schoen RT, Taylor E, Hutchinson GJ, Rahn DW, Malawista SE.

N Engl J Med. 1985 Apr 4;312(14):869-74.

PMID:
3883177
9.

Failure of tetracycline therapy in early Lyme disease.

Dattwyler RJ, Halperin JJ.

Arthritis Rheum. 1987 Apr;30(4):448-50.

PMID:
3580012
10.

Ceftriaxone as effective therapy in refractory Lyme disease.

Dattwyler RJ, Halperin JJ, Pass H, Luft BJ.

J Infect Dis. 1987 Jun;155(6):1322-5. No abstract available.

PMID:
3572042
11.

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Johnson RC, Kodner C, Russell M.

Antimicrob Agents Chemother. 1987 Feb;31(2):164-7. Erratum in: Antimicrob Agents Chemother 1990 Aug;34(8):1622.

12.

Treatment of erythema chronicum migrans of Lyme disease.

Berger BW.

Ann N Y Acad Sci. 1988;539:346-51.

PMID:
3190102
13.

New chemotherapeutic approaches in the treatment of Lyme borreliosis.

Luft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ.

Ann N Y Acad Sci. 1988;539:352-61.

PMID:
3056203
14.

Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.

Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Wilske B, Schierz G, Marget W.

Ann N Y Acad Sci. 1988;539:324-45.

PMID:
3056202
15.

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.

Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG.

N Engl J Med. 1988 Dec 1;319(22):1441-6.

PMID:
3054554
16.

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.

Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ.

Lancet. 1988 May 28;1(8596):1191-4.

PMID:
2897008
17.

Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.

Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JL.

J Clin Microbiol. 1990 Feb;28(2):363-5.

18.
19.

Lyme disease assay which detects killed Borrelia burgdorferi.

Callister SM, Schell RF, Lovrich SD.

J Clin Microbiol. 1991 Sep;29(9):1773-6.

Supplemental Content

Support Center